首页> 外文期刊>Seminars in ophthalmology >Combined Non-Penetrating Deep Scierectomy with Phacoemolsiflcation Versus Non-Penetrating Deep Sclerectomy Alone
【24h】

Combined Non-Penetrating Deep Scierectomy with Phacoemolsiflcation Versus Non-Penetrating Deep Sclerectomy Alone

机译:非穿透性深层巩膜切除术与单独的超声乳化结合非穿透性深层巩膜切除术

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To compare the results of combined non-penetrating deep sclerectomy with phacoemulsification (Phaco-NPDS) to those of non-penetrating deep sclerectomy (NPDS) alone. Materials and Methods: Fifty-two eyes with cataract and primary open angle glaucoma (POAG) or pseudoexfoliative glaucoma (PXG) were randomly assigned to either Phaco-NPDS or NPDS. Follow-up was performed at regular intervals for up to 36 months. Complete success was defined as intraocular pressure (IOP) <21mmHg without medication and qualified success was defined as IOP <21 mmHg with medication. Results: Mean IOP in the Phaco-NPDS group decreased from 23.0 ± 7.8 mmHg to 14.1 ± 2.8 mmHg and in the NPDS group from 23.5 ± 5.1 to 14.6 ± 2.2 mmHg 24 months after surgery. The decreases of IOP in the postoperative period were statistically significant in both groups (p<0.05). There was no significant IOP difference between Phaco-NPDS and NPDS patients postoperatively (p>0.05). The mean number of glaucoma medications decreased from 1.8±1.3 to 0.15±0.4 and from 1.7 + 1.4 to 0.22±0.6 in the Phaco-NPDS and NPDS groups, respectively. The decreases in the mean number of the anti-glaucoma medications at the end of the postoperative, 24-month follow-up period were found to be statistically significant for both Phaco-NPDS and NPDS groups (p<0.05). Mean BCVA increased significantly in both groups. However, the visual outcome was significantly better for the Phaco-NPDS group (p<0.05). The complete and qualified success rates were 65.3% and 88.4% for Phaco-NPDS patients and 73.1% and 92.3% for NPDS patients, respectively (p>0.05). Conclusion: Phaco-NPDS surgery achieved excellent IOP control, while also providing immediate visual recovery. The success rate was similar to that of the NPDS procedure alone. It is advisable to consider Phaco-NPDS as a primary surgery for patients with coexisting cataract and open angle glaucoma, including PXG.
机译:目的:比较非穿透性深层巩膜切除术与单独的非穿透性深层巩膜切除术(NPDS)的结果,以比较非穿透性深层巩膜切除术联合超声乳化(Phaco-NPDS)的结果。材料和方法:52只患有白内障和原发性开角型青光眼(POAG)或假性剥脱性青光眼(PXG)的眼睛被随机分配给Phaco-NPDS或NPDS。定期进行长达36个月的随访。完全成功的定义为无药物治疗的眼内压(IOP)<21mmHg,合格的成功定义为药物治疗的眼压<21 mmHg。结果:术后24个月,Phaco-NPDS组的平均IOP从23.0±7.8 mmHg降低到14.1±2.8 mmHg,NPDS组的平均IOP从23.5±5.1 mmHg降低到14.6±2.2 mmHg。两组术后IOP的降低均具有统计学意义(p <0.05)。术后Phaco-NPDS与NPDS患者之间的IOP没有显着差异(p> 0.05)。在Phaco-NPDS和NPDS组中,青光眼药物的平均数量分别从1.8±1.3降至0.15±0.4,从1.7 + 1.4降至0.22±0.6。在Phaco-NPDS组和NPDS组,术后24个月的随访期末,抗青光眼药物平均剂量的减少具有统计学意义(p <0.05)。两组的平均BCVA均显着增加。但是,Phaco-NPDS组的视觉效果明显更好(p <0.05)。 Phaco-NPDS患者的完全和合格成功率分别为65.3%和88.4%,NPDS患者的分别为73.1%和92.3%(p> 0.05)。结论:Phaco-NPDS手术可实现出色的IOP控制,同时还可以立即恢复视力。成功率仅与NPDS程序相似。建议将Phaco-NPDS作为患有白内障和开角型青光眼(包括PXG)的患者的主要手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号